Home›Elvitegravir Cobicistat Emtricitabine And Tenofovir Alafenam›Elvitegravir Cobicistat Emtricitabine And Tenofovir Alafenam + Other Antiretroviral Medications For Treatment Of Hiv 1 Infe

Does Elvitegravir Cobicistat Emtricitabine And Tenofovir Alafenam Interact with Other Antiretroviral Medications For Treatment Of Hiv 1 Infe?

Elvitegravir Cobicistat Emtricitabine And Tenofovir Alafenam and Other Antiretroviral Medications For Treatment Of Hiv 1 Infe have a contraindicated drug interaction according to U.S. FDA drug labeling data. GENVOYA is a complete regimen and coadministration with other antiretroviral medications should be avoided. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Contraindicated
Elvitegravir Cobicistat Emtricitabine And Tenofovir Alafenam Class
Cytochrome P450 3A Inhibitor
Management
Do not take together
Data Source
U.S. FDA via OpenFDA

What To Tell Your Doctor or Pharmacist

If you are taking Elvitegravir Cobicistat Emtricitabine And Tenofovir Alafenam and your doctor is considering prescribing Other Antiretroviral Medications For Treatment Of Hiv 1 Infe (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask about alternative medications that do not interact with your current regimen
  • Ask how frequently you should be monitored while these are co-prescribed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Elvitegravir Cobicistat Emtricitabine And Tenofovir Alafenam(Genvoya)+💊 Other Antiretroviral Medications For Treatment Of Hiv 1 Infe(Selsun Blue)

Severity & Interaction Details

⛔
contraindicated
Avoid this combination
FDA labeling lists this pair as contraindicated. The risk outweighs the benefit in nearly all cases.
Severity scale
MinorContra
On record
Yes
Drug A class
Cytochrome P450 3A Inhibitor
Drug B class
—
Source
NLP:elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide

What this means in plain English

GENVOYA is a complete regimen and coadministration with other antiretroviral medications should be avoided.

About Elvitegravir Cobicistat Emtricitabine And Tenofovir Alafenam and Other Antiretroviral Medications For Treatment Of Hiv 1 Infe

Elvitegravir Cobicistat Emtricitabine And Tenofovir Alafenam is a Cytochrome P450 3A Inhibitor. You may recognize them by the brand names Genvoya and Selsun Blue. Elvitegravir Cobicistat Emtricitabine And Tenofovir Alafenam is taken by mouth. Elvitegravir Cobicistat Emtricitabine And Tenofovir Alafenam additionally carries an FDA boxed warning, the FDA's strongest safety alert.

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Elvitegravir Cobicistat Emtricitabine And Tenofovir Alafenam and Other Antiretroviral Medications For Treatment Of Hiv 1 Infe against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →
Data integrity: Every interaction shown is extracted directly from official U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NIH) — no interactions are invented, inferred, or manually edited. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.